Lotte Meijerink

Dr. Lotte Meijerink

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
LMLotte Meijerink
Lotte Meijerink
IOI. M. van Ooijen
I. M. van Ooijen
TAT. Alderliesten
T. Alderliesten
FTF. Terstappen
F. Terstappen
MBM. J. N. L. Benders
M. J. N. L. Benders
MBM. N. Bekker
M. N. Bekker
This systematic review investigates potential differences in brain development between growth restricted (FGR)-fetuses compared to appropriate for gestational age (AGA) fetuses using MRI. PubMed, Embase, Cochrane Library and Web of Science databases were searched from 1985 to 2023. FGR was defined as an estimated fetal weight (EFW) < p10 and/or an abdominal circumference (AC) < p10, or 20% reduction in EFW or AC using a minimum interval of two weeks. Outcomes included volumetrics, biometrics, apparent diffusion coefficients (ADC), 1H-MRS-metabolites, and oxygenation of the fetal brain. Risk of bias was assessed using Newcastle-Ottawa Scale (NOS). A meta-analysis was conducted on variables when reported in at least three studies, calculating the mean difference (MD) with a 95% confidence interval (CI). Twenty-nine studies were included after three-phase screening, 13 used the FGR consensus definition according to the Delphi procedure. Total brain volume and cerebellar volume were significantly reduced in FGR fetuses (n = 183; 74) when compared to AGA fetuses (n = 283; 166) with a MD of -30.84 cm3 (p < 0.01) and − 2.24 cm3 (p < 0.01). ADC values in the frontal white matter (FWM), occipital white matter (OWM), temporal white matter (TWM), thalami, centrum semiovale (CSO), basal ganglia, pons and cerebellum, significantly lower in growth restricted fetuses (-0.07 × 10–3 mm2/s (p < 0.01); -0.06 × 10–3 mm2/s (p < 0.01); -0.07 × 10–3 mm2/s (p < 0.01); -0.10 × 10–3 mm2/s (p < 0.01); -0.06 × 10–3 mm2/s (p < 0.01); -0.07 × 10–3 mm2/s (p < 0.01); -0.07 × 10–3 mm2/s (p < 0.01); -0.02 × 10–3 mm2/s (p < 0.01); respectively). 1H-MRS showed reduced levels of N-acetyl aspartate (NAA): Choline (Cho) and NAA: Creatine(CR) levels in the frontal lobe and central brain tissue, whilst contradictive findings concerning Cho: Cr and Inositol(Ino): Cho ratios were found. Two studies investigated the cerebral hemodynamic changes in FGR fetuses showing no difference in fractional moving blood volume, similar venous blood oxygenation in the superior sagittal sinus and no difference in T2* in the fetal brain. MRI provides additional information on fetal brain development in a growth restricted population. Smaller total brain and cerebellar volumes and lower ADC values in the FWM, OWM, TWM, thalami, CSO, basal ganglia, pons and cerebellum have been observed in FGR. These conclusions are drawn on relatively small sample sizes with high heterogeneity resulting from diverse study populations and MRI techniques. Furthermore, how these findings correlate to long-term neurocognitive abnormalities associated with FGR remains to be elucidated. A large cohort study comparing brain maturation, myelination, metabolic and hemodynamic status between brain-sparing FGR fetuses to healthy age-matched controls is needed.

20 February 2023 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
LMLotte Meijerink
Lotte Meijerink
KWKim E. Wever
Kim E. Wever
FTFieke Terstappen
Fieke Terstappen
WGWessel Ganzevoort
Wessel Ganzevoort
ALA. Titia Lely
A. Titia Lely
MDMartine Depmann
Martine Depmann
Background: Several human randomised controlled trials (RCTs) are investigating the effects of statins on pre‐eclampsia (PE) and fetal growth restriction (FGR). This cross‐species meta‐analysis summarises the preclinical evidence of statin use for PE and FGR.Objectives: Evaluate the effects of statins on maternal blood pressure (MBP) and birthweight (BW) in pregnancies complicated by PE or FGR.Search Strategy: PubMed and Embase.com were searched on 10 May 2022 using ‘statins’ and ‘pregnancy’.Selection Criteria: We included RCTs and cohorts with matched control groups as well as animal studies.Data Collection and Analysis: The main outcomes were MBP in mmHg and BW in grams. The standardised mean difference (SMD) with a 95% confidence interval (CI) was calculated. Subgroup analyses on species, statin, dose, timing and route of administration were performed if subgroups included at least three studies.Main Results: Our data included one human and 12 animal studies. Prenatal administration of statins significantly reduced MBP during pregnancy (SMD −2.49 mmHg [95% CI −4.26 to −0.71], p = 0.01). There was no significant effect of statins on BW (SMD 0.69 [95% CI −0.65 to 2.03], p = 0.28). Our subgroup analyses showed no effect on MBP of different doses, species or route of administration.Conclusions: Our cross‐species meta‐analyses demonstrate that statins only reduce maternal blood pressure in rodent pregnancies complicated by pre‐eclampsia or fetal growth restriction and have no effect on birthweight across species. The broad confidence intervals, inconsistent direction of the observed effects across the studies and large risk of bias lead us to conclude that a solid base for further human RCTs is lacking.

17 August 2023 in Cells
Verified
Journal Article
Open access
PDF file
FDFatimah Al Darwish
Fatimah Al Darwish
LMLotte Meijerink
Lotte Meijerink
BCBram Coolen
Bram Coolen
GSGustav Strijkers
Gustav Strijkers
MBMireille Bekker
Mireille Bekker
FTFieke Terstappen
Fieke Terstappen
Placental hypoxia poses significant risks to both the developing fetus and the mother during pregnancy, underscoring the importance of early detection and monitoring. Effectively identifying placental hypoxia and evaluating the deterioration in placental function requires reliable biomarkers. Molecular biomarkers in placental tissue can only be determined post-delivery and while maternal blood biomarkers can be measured over time, they can merely serve as proxies for placental function. Therefore, there is an increasing demand for non-invasive imaging techniques capable of directly assessing the placental condition over time. Recent advancements in imaging technologies, including photoacoustic and magnetic resonance imaging, offer promising tools for detecting and monitoring placental hypoxia. Integrating molecular and imaging biomarkers may revolutionize the detection and monitoring of placental hypoxia, improving pregnancy outcomes and reducing long-term health complications. This review describes current research on molecular and imaging biomarkers of placental hypoxia both in human and animal studies and aims to explore the benefits of an integrated approach throughout gestation.

23 January 2026 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
LMLotte Meijerink
Lotte Meijerink
MWM. Wyburd
M. Wyburd
ANA. I. L. Namburete
A. I. L. Namburete
TAT. Alderliesten
T. Alderliesten
FGF. Groenendaal
F. Groenendaal
MBM. N. Bekker
M. N. Bekker
Objectives: To quantify fetal brain maturation in fetuses with early‐onset fetal growth restriction (FGR) by estimating gestational age (GA) based on the appearance of gyrification and individual brain structures from three‐dimensional (3D) ultrasound volumes using a deep‐learning model trained on optimally developing subjects. The association of altered fetal brain maturation, as a potential marker of cumulative intrauterine stress, with an increased risk of neonatal complications was also explored. Methods: This was a prospective, observational, single‐center cohort study of singleton pregnancies with early‐onset FGR conducted at the University Medical Center Utrecht between June 2022 and June 2024. Early‐onset FGR was defined as an estimated fetal weight (EFW) and/or abdominal circumference below the 10 th percentile before 32 weeks' gestation, and brain sparing was defined as an umbilical artery pulsatility index (PI) above the 95 th percentile in combination with a middle cerebral artery PI below the 5 th percentile or a cerebroplacental ratio (CPR) < 1. Fetal brain maturation was determined using a deep‐learning model, which was trained on data from an optimally developing cohort at GAs of between 18 + 0 and 28 + 6 weeks, collected by the INTERGROWTH‐21 st Consortium. Therefore, only fetuses with a GA of < 29.0 weeks at the time of the scan were included in the analysis. Estimation of brain maturation was based on the size and shape of the Sylvian fissure (SF), parieto‐occipital fissure (POF) and calcarine sulcus (CLC), cerebellum (CB) and the combination of all fissures using the whole‐brain ultrasound scan. The mean difference between estimated GA and actual GA (ΔGA) in days was calculated. In a subgroup analysis, ΔGA for brain‐sparing FGR was compared with ΔGA for non‐brain‐sparing FGR. Regression analysis was performed to examine the relationship between brain maturation data and potential covariates. Results: The study included 43 growth‐restricted fetuses with high‐quality 3D ultrasound scans (13 of which had brain‐sparing FGR) at a median GA of 27.1 (interquartile range (IQR), 26.1–27.7) weeks. The estimated GA was significantly lower than the actual GA in early‐onset FGR, with ΔGA of –4.6 (IQR, –9.8 to –1.0) days based on the whole scan, ΔGA of –4.9 (IQR, –9.0 to –1.2) days based on the SF, ΔGA of –5.4 (IQR, –7.4 to –1.7) days based on the POF and CLC, and ΔGA of –3.2 (IQR, –6.8 to 0.3) days based on the CB ( P < 0001 for all). There was no significant difference in brain maturation between fetuses with brain‐sparing and those with non‐brain‐sparing FGR or between male and female fetuses. The EFW percentile correlated significantly with the degree of delayed maturation (whole‐scan data, r = 0.377; P = 0.013) and contributed to our multivariable model. Socioeconomic status, fetal sex and CPR were not associated with the delay in maturation. Seventeen neonates were born < 32.0 weeks' gestation and admitted to the neonatal intensive care unit. The ΔGA was higher in the neonates with perinatal complications, indicating greater delay in brain maturation. Conclusions: Delayed fetal brain maturation in early‐onset FGR has been demonstrated using a 3D ultrasound deep‐learning model. These findings highlight the potential role of 3D ultrasound in the assessment of fetal brain maturation and support the need for continued research into these findings and their long‐term neurodevelopmental consequences in early‐onset FGR. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

3 July 2025 in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Verified
Journal Article
Open access
LMLotte Meijerink
Lotte Meijerink
IOInge van Ooijen
Inge van Ooijen
FTFieke Terstappen
Fieke Terstappen
TAThomas Alderliesten
Thomas Alderliesten
RNRutger A.J. Nievelstein
Rutger A.J. Nievelstein
MBMireille Bekker
Mireille Bekker
To identify volumetric and diffusion-related brain differences expressed as apparent diffusion coefficient (ADC) values between early-onset brain-sparing fetal growth restriction (FGR) and healthy controls using magnetic resonance imaging (MRI) at 30 weeks of gestation. This prospective, observational, monocenter cohort study included singleton pregnancies with early-onset brain-sparing FGR at the University Medical Center Utrecht. FGR fetuses were compared to healthy controls from the Utrecht YOUth Cohort. Fetal MRI of the brain was performed including T2-weighted and diffusion weighted imaging (DWI) sequences. We measured 2D biometrics, 3D volumetrics using BOUNTI, and ADC values in multiple brain and placental regions. Values were corrected to 30 weeks of gestation. The study included 26 FGR fetuses at gestational age (GA) 26.3–32 weeks and 71 controls at GA 30.1–34 weeks. At 30 weeks, total brain volume (TBV) was significantly smaller in FGR (144.2 ± 11.5 vs 166.9 ± 17.5 milliliters, p < 0.001). After dividing all absolute volumes by TBV, only cerebellar volume remained significantly reduced (0.045 [0.00] vs 0.048 [0.01], p = 0.006). ADC values were lower in all brain regions except the cerebellum. Placental ADC values were also significantly lower in FGR. Altered brain development in brain-sparing FGR is already present at 30 weeks of gestation. Lower brain volumes and ADC values may reflect the effects of altered perfusion, chronic hypoxia and microstructural changes in the brains of FGR fetuses. Future studies linking these MRI findings to long-term neurodevelopmental outcomes will aid in more personalized prognoses and might also inform the timing of delivery, ultimately enhancing clinical decision-making.

3 December 2025 in NeuroImage
Verified
Journal Article
Open access
IOInge M. van Ooijen
Inge M. van Ooijen
GIGaby van Iersel
Gaby van Iersel
LMLotte Meijerink
Lotte Meijerink
JTJalmar Teeuw
Jalmar Teeuw
ETElise Turk
Elise Turk
MBManon J.N.L. Benders
Manon J.N.L. Benders
Recent advances in fetal three-dimensional (3D) ultrasound (US) enable automated intracranial volume (ICV) measurements. If US yields results comparable to magnetic resonance imaging (MRI), it could serve as a fast, cost-effective, and scalable alternative. This study directly compares and visualizes ICV measurements from fetal 3D US and 3D MRI. We applied automated ICV segmentation to US and MRI data from healthy participants. In a subset of fetuses who underwent both US and MRI within 24 hours, we evaluated ICV agreement using the intraclass correlation coefficient (ICC) and the Dice similarity coefficient (DSC). As a proof of principle, we also generated a multimodal ICV trajectory incorporating fetal US, fetal MRI, and neonatal MRI. Among the 71 participants, 47 had high-quality US scans at 20 and 30 weeks of gestation, 61 had high-quality fetal MRI, and 47 had high-quality neonatal MRI. Thirteen fetuses around 30 weeks had US and MRI scans acquired within 24 hours, showing good agreement with an ICC of 0.797 and DSCUS-MRI scores of 0.900-0.925. Mean ICV values were 80 ± 12 ml around 22 weeks (US), 248 ± 28 ml around 30 weeks (US), 294 ± 36 ml around 32 weeks (fetal MRI) and 508 ± 51 ml around 43 weeks (neonatal MRI). Fetal US and MRI yield comparable ICV measurements around 30 weeks of gestation, validating automatic 3D US volumetric methods. The use of 3D US may support development of normative curves and improve comparisons with at-risk fetuses, including in regions where fetal MRI is less accessible.